Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.42 USD
+0.15 (0.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $65.42 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 1.60 |
EPS Last Quarter | -1.32 |
Last EPS Surprise | 11.41% |
ABR | 2.20 |
Earnings ESP
|
0.22% |
---|---|
Current Year | 3.83 |
Next Year | 7.24 |
EPS (TTM) | 4.03 |
P/E (F1) | 17.08 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.75B | 7.03B | 27.50B | 27.93B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 6.87B | 7.19B | 27.76B | 28.86B |
Low Estimate | 6.49B | 6.89B | 27.26B | 27.38B |
Year ago Sales | 6.60B | 7.05B | 27.12B | 27.50B |
Year over Year Growth Est. | 2.23% | -0.27% | 1.39% | 1.57% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.60 | 1.82 | 3.83 | 7.24 |
# of Estimates | 10 | 10 | 9 | 13 |
Most Recent Consensus | 1.40 | 1.84 | 3.69 | 7.24 |
High Estimate | 1.78 | 2.06 | 4.64 | 7.80 |
Low Estimate | 1.40 | 1.64 | 3.55 | 6.61 |
Year ago EPS | 1.34 | 2.29 | 6.72 | 3.83 |
Year over Year Growth Est. | 19.40% | -20.52% | -43.01% | 88.99% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 3 |
Up Last 30 Days | 0 | 1 | 0 | 2 |
Up Last 60 Days | 0 | 1 | 0 | 2 |
Down Last 7 Days | 4 | 5 | 5 | 3 |
Down Last 30 Days | 8 | 7 | 9 | 7 |
Down Last 60 Days | 8 | 7 | 9 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.60 | 1.82 | 3.83 | 7.24 |
7 Days Ago | 1.63 | 1.88 | 4.96 | 7.26 |
30 Days Ago | 1.66 | 1.91 | 7.07 | 7.50 |
60 Days Ago | 1.66 | 1.91 | 7.07 | 7.50 |
90 Days Ago | 1.77 | 1.94 | 7.41 | 7.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.61 | 1.79 | 3.83 | 7.18 |
Zacks Consensus Estimate | 1.60 | 1.82 | 3.83 | 7.24 |
Earnings ESP | 0.22% | -1.47% | 0.00% | -0.81% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.32 | 1.72 | 2.29 | 1.34 | NA |
Estimate | -1.49 | 1.76 | 1.91 | 1.60 | NA |
Difference | 0.17 | -0.04 | 0.38 | -0.26 | 0.06 |
Surprise | 11.41% | -2.27% | 19.90% | -16.25% | 3.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more